Gong et al reported a simple clinical prognostic score for evaluating patients with advanced non-small cell lung cancer (NSCLC). This can help to identify a patient who may benefit from more aggressive management or a novel intervention. The authors are from the First Hospital of China Medical University in Shenyang, China.